Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziad Bakouny

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Nature Medicine|May 15, 2020
IL-8 and cancer prognosis on immunotherapyZiad Bakouny, Toni K Choueiri
Cancer Discovery|March 5, 2020
TBK1 Activation by VHL Loss in Renal Cell Carcinoma: A Novel HIF-Independent VulnerabilityZiad Bakouny, David A Barbie
JCO Clinical Cancer Informatics|August 12, 2021
Machine Learning and Real-World Data: More than Just BuzzwordsZiad Bakouny, Debra A Patt
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney CancerPraful Ravi, Ziad Bakouny, Andrew Schmidt, et al.
Future Oncology (London, England)|March 13, 2018
Different inhibitors for the same target in metastatic luminal breast cancer: is there any difference?Elie El Rassy, Ziad Bakouny, Tarek Assi, et al.
Journal of Clinical Gastroenterology|December 22, 2018
Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsZiad Bakouny, Tarek Assi, Elie El Rassy, et al.
Le Journal Medical Libanais. the Lebanese Medical Journal|August 30, 2017
A NEW APPROACH IN THE CLINICAL DECISION-MAKING FOR CEREBRAL PALSY USING THREE-DIMENSIONAL SUBJECT-SPECIFIC MUSCULOSKELETAL RECONSTRUCTIONSAbir Massaad, Ayman Assi, Ziad Bakouny, et al.
Ebiomedicine|June 26, 2024
PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?Ziad Bakouny, David A Braun, Ed Reznik, et al.
Nature Reviews. Urology|July 31, 2025
Biomarkers for renal cell carcinoma - a pragmatic approachZiad Bakouny, A Ari Hakimi, Ed Reznik, et al.
Immunotherapy|June 13, 2019
The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?Elie Rassy, Ziad Bakouny, Tarek Assi, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Nature Medicine|May 15, 2020
IL-8 and cancer prognosis on immunotherapyZiad Bakouny, Toni K Choueiri
Cancer Discovery|March 5, 2020
TBK1 Activation by VHL Loss in Renal Cell Carcinoma: A Novel HIF-Independent VulnerabilityZiad Bakouny, David A Barbie
JCO Clinical Cancer Informatics|August 12, 2021
Machine Learning and Real-World Data: More than Just BuzzwordsZiad Bakouny, Debra A Patt
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney CancerPraful Ravi, Ziad Bakouny, Andrew Schmidt, et al.
Future Oncology (London, England)|March 13, 2018
Different inhibitors for the same target in metastatic luminal breast cancer: is there any difference?Elie El Rassy, Ziad Bakouny, Tarek Assi, et al.
Journal of Clinical Gastroenterology|December 22, 2018
Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsZiad Bakouny, Tarek Assi, Elie El Rassy, et al.
Le Journal Medical Libanais. the Lebanese Medical Journal|August 30, 2017
A NEW APPROACH IN THE CLINICAL DECISION-MAKING FOR CEREBRAL PALSY USING THREE-DIMENSIONAL SUBJECT-SPECIFIC MUSCULOSKELETAL RECONSTRUCTIONSAbir Massaad, Ayman Assi, Ziad Bakouny, et al.
Ebiomedicine|June 26, 2024
PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?Ziad Bakouny, David A Braun, Ed Reznik, et al.
Nature Reviews. Urology|July 31, 2025
Biomarkers for renal cell carcinoma - a pragmatic approachZiad Bakouny, A Ari Hakimi, Ed Reznik, et al.
Immunotherapy|June 13, 2019
The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?Elie Rassy, Ziad Bakouny, Tarek Assi, et al.
Pageof 13